Now Available! MyCell Cardiomyocytes HCM (R403Q) and Isogenic Control. Take advantage of the latest additions to our cardiac suite. These cardiomyocytes are perfectly suited for diseased modeling studies aimed at understanding the physiological consequences of the most common mutation causing hypertrophic cardiomyopathy (HCM) and developing treatments for HCM.
FUJIFILM Cellular Dynamics Announces Agreement with University of California - Irvine to Commercialize iPSC-derived Microglia and Media Formulation. Learn about this agreement that will enable us to provide scientists worldwide with access to these brain cells for use in the research of afflictions such as Alzheimer’s disease.
ISSCR 2018 Presentations. Delve into our conference posters that detail how iCell and MyCell products were used to generate human microglia, investigate TDP-43 mutations, and evaluate hypertrophic cardiomyopathy.